Medical News

RSS

Review explores diagnosis and management of perioperative anaphylaxis during anesthesia

Perioperative anaphylaxis is a rare, life‑threatening condition during anesthesia. The unique setting – multiple drugs, patient draping, and altered physiology – causes higher mortality than anaphylaxis elsewhere.

29 May 2026

Review explores complex associations between sleep apnea and lung cancer

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent hypoxia and sleep fragmentation, which may contribute to lung cancer development and progression.

29 May 2026

Grant funds research into molecular memories behind exaggerated fear

Experiencing a traumatic event sometimes produces long-lasting biological changes that can lead to an exaggerated fear response to future stressful events, such as what occurs in individuals with post-traumatic stress disorder (PTSD).

29 May 2026

Survey reveals critical knowledge gaps in maternal health recommendations

Most Americans know that how well a mother takes care of herself before and during pregnancy affects the health of a baby, but many people remain unclear about some specific maternal health recommendations, including when to start avoiding alcohol, according to a new nationally representative survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

29 May 2026

Healthy lifestyles reduce chronic health risks for childhood cancer survivors

Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors. These are the findings of two new international studies.

29 May 2026

Targeted therapy sunvozertinib outperforms standard chemotherapy in advanced lung cancer trial

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations (EGFR exon20ins), according to new research from The University of Texas MD Anderson Cancer Center.

29 May 2026

Novel therapeutic agent proposed to combat drug resistant tuberculosis

A research team led by Associate Professor Noriyuki Kurita from the Department of Computer Science and Engineering at Toyohashi University of Technology and by Associate Professor Pornpan Pungpo from Ubon Ratchathani University in Thailand has proposed a novel therapeutic agent for tuberculosis, using high-precision molecular simulation techniques.

29 May 2026

Herbal cigarettes are not safer than regular tobacco alternatives

Herbal cigarettes, widely sold in India and abroad as natural, tobacco-free, and even therapeutic alternatives to conventional cigarettes, are not safer than regular tobacco cigarettes.

29 May 2026

Unhealthy snacks drive disruptive behavior in young children

Researchers at the University of Agder (UiA) have already identified clear links between what children eat and their mental health as early as the age of four.

29 May 2026

New approach helps design better antibiotics to fight drug-resistant infections

A new way of designing antibiotics could support the discovery of new treatments for drug-resistant infections.

29 May 2026

Sociological shifts change expectations and behaviors of modern patients

Whereas patients in the past were expected to be patient, grateful, passive and docile - many of today's patients are assertive, demanding, impatient and insistent. So, what has happened?

29 May 2026

Immediate kangaroo mother care boosts survival for premature infants

Preterm birth and low birth weight remain major contributors to neonatal death and long-term developmental challenges.

29 May 2026

PET microplastics remain in lungs and worsen respiratory tract inflammation

Microplastics (MP) are the subject of intensive medical research, but little is yet known about their effects on the immune system.

29 May 2026

Study reveals right ventricle better tolerates oxygen loss during cardiac arrest

A study led by scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) provides new insights into ventricular fibrillation (VF), the most dangerous type of cardiac arrhythmia.

29 May 2026

4basebio launches high-performance enzymatic ssDNA platform to accelerate next-generation gene editing

4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines.

From 4basebio PLC 29 May 2026